Adrenal disease

The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study

J Clin Endocrinol MetabPublished Mechanistic study

Authors' conclusion

In the context of a low-renin phenotype, there is a continuum of primary aldosteronism and dysregulated aldosterone production that is prominently influenced by ACTH. A large proportion of individuals with low renin may benefit from aldosterone-directed therapy.

Study context

Population
Individuals with a low-renin phenotype across the BP continuum (severe/resistant hypertension, hypertension with hypokalemia, elevated BP and stage I/II hypertension, normal BP); 4 international centerslow-renin phenotype
Participants
348 individuals
Comparison
Severe and/or resistant hypertension vs Hypertension with hypokalemia vs elevated blood pressure and stage I/II hypertension vs normal blood pressure
Outcome
Magnitude of renin-independent aldosteronism (SST), ACTH-mediated aldosteronism (dexamethasone suppression and ACTH-stimulation tests), and lateralization (adrenal venous sampling)
Methodological detailshuman physiology study, multicentre (4 international centers)
  • Human physiology study
  • Multicentre (4 international centers)

Main finding

As reported in the abstract

Correlation of post-SST aldosterone with ACTH-stimulated aldosterone production

r = 0.75

P < .0001

Correlation of post-SST aldosterone with nonsuppressible aldosterone postdexamethasone

r = 0.40

P < .0001

Further findings

Lateralizing aldosteronism below PA diagnostic threshold (post-SST aldosterone <10 ng/dL or <277 pmol/L)

Lateralizing aldosteronism amenable to surgical adrenalectomy
15%
Remainder treated with mineralocorticoid receptor antagonists

Original publication

The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study. J Clin Endocrinol Metab. Published 7 March 2024. doi:10.1210/clinem/dgae145

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.